![Steven Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 36 $ al 30/06/2026
Steven Kelly was the founder of CTx Operations, Inc., founded in 2018, serving as President & Chief Executive Officer from 2018 to 2025.
Mr. Kelly is currently an Independent Director at Artelo Biosciences, Inc. since 2017.
Former positions include President & Chief Executive Officer at Innovive Pharmaceuticals, Inc. from 2004 to 2010; Chief Commercial Officer at BioVex, Inc. from 2010 to 2011; Chief Executive Officer at Theracrine, Inc. from 2011 to 2012; Principal at Kelly Bioconsulting LLC from 2012 to 2018; President, Chief Executive Officer & Director at Carisma Therapeutics, Inc. from 2018 to 2025; Chief Executive Officer at Carisma Therapeutics, Inc. from 2025 to 2026; and President & Chief Executive Officer at Pinteon Therapeutics, Inc. from 2014 to 2015.
Education includes an MBA from Cornell University and an undergraduate degree from the University of Oregon.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/07/2026 | 47 ( 0 % ) | 36 $ | 31/07/2026 | |
| 31/05/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Director/Miembro de la Junta | 02/05/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director Ejecutivo | 01/01/2026 |
| CARISMA THERAPEUTICS, INC. | Director Ejecutivo | 15/11/2025 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Director Ejecutivo | 01/11/2025 |
Kelly Bioconsulting LLC
 Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | 01/01/2018 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Director Ejecutivo | 01/07/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
Kelly Bioconsulting LLC
Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
